Table 1. Demographic and Clinical Characteristics of the Sample.
| Non-Alcoholic Fatty Liver Disease Group (n = 57) | |||
|---|---|---|---|
| Total (n = 57) | Females (n = 18) | Males (n = 39) | |
| Age, y, Mean ± SD | 12.07 ± 3.00 | 11.22 ± 3.11 | 12.46 ± 2.9 |
| Age at Onset, y, Mean ± SD | 10 ± 3.00 | 9.06 ± 2.94 | 9.92 ± 2.67 |
| Familiar Psychiatric History, P/A | 14/43 | 3/13 | 9/30 |
| BMI, kg/m2, Mean ± SD | 27.05 ± 3.75 | 27.85 ± 3.76 | 26.68 ± 3.74 |
| HOMA-IR, Mean ± SD | 2.53 ± 1.27 | 3.07 ± 1.52 | 2.28 ± 1.06 |
| Liver Enzymes-AST, Mean ± SD | 69.50 ± 57.69 | 67.83 ± 84.79 | 70.28 ± 41.07 |
| Liver Enzymes-ALT, Mean ± SD | 47.00 ± 22.92 | 43.44 ± 30.08 | 48.69 ± 18.98 |
| Cholesterol Levels, Mean ± SD | 159.7 0± 35.37 | 162.77 ± 28.89 | 158.38 ± 38.25 |
| Triglyceride Levels, Mean ± SD | 105.30± 62.08 | 93.27 ± 37.98 | 110.84 ± 70.25 |
| Cytokines-IL-6, Mean± SD | 10.60 ± 7.50 | 11.32 ± 9.38 | 10.14 ± 6.21 |
| Cytokines-TNF-α, Mean ± SD | 22.08 ± 34.50 | 18.29 ± 16.68 | 24.11 ± 41.23 |
Abbreviations: ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; BMI, Body Mass Index; HOMA-IR, Homeostasis Model Assessment–Insulin Resistance; IL, Interleukine-6; P/A, Presence/Absence; TNF, Tumor Necrosis Factor-alpha